Neuropathic Pain Drug Market Research Report by Type (Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy, and Trigeminal Neuralgia), by Treatment (Antidepressant Drugs Type, Medication Type, Multimodal Therapy, and NSAIDs Type), by Indication, by Diagnosis, by Distribution, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neuropathic Pain Drug Market is expected to grow from USD 8,800.80 Million in 2020 to USD 13,380.73 Million by the end of 2025.
2. The Global Neuropathic Pain Drug Market is expected to grow from EUR 7,716.71 Million in 2020 to EUR 11,732.48 Million by the end of 2025.
3. The Global Neuropathic Pain Drug Market is expected to grow from GBP 6,860.17 Million in 2020 to GBP 10,430.20 Million by the end of 2025.
4. The Global Neuropathic Pain Drug Market is expected to grow from JPY 939,269.04 Million in 2020 to JPY 1,428,063.94 Million by the end of 2025.
5. The Global Neuropathic Pain Drug Market is expected to grow from AUD 12,779.94 Million in 2020 to AUD 19,430.61 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Neuropathic Pain Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Neuropathic Pain Drug Market studied across Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy, and Trigeminal Neuralgia.
Based on Treatment, the Neuropathic Pain Drug Market studied across Antidepressant Drugs Type, Medication Type, Multimodal Therapy, and NSAIDs Type. The Antidepressant Drugs Type further studied across Serotonin Noradrenaline and Tricyclic Antidepressants. The NSAIDs Type further studied across Ibuprofen and Naproxen.
Based on Indication, the Neuropathic Pain Drug Market studied across Diabetic Neuropathy and Spinal Stenosis.
Based on Diagnosis, the Neuropathic Pain Drug Market studied across Blood Tests and Imaging Physical Examination. The Imaging Physical Examination further studied across CT, Electromyography, and MRI.
Based on Distribution, the Neuropathic Pain Drug Market studied across Online Pharmacies and Retail Pharmacies & Drug Stores.
Based on End User, the Neuropathic Pain Drug Market studied across Clinics and Hospitals.
Based on Geography, the Neuropathic Pain Drug Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuropathic Pain Drug Market including Baxter Healthcare Corporation, Biogen Idec Inc., Bristol-Myers Squibb and Company, Depomed Inc., Eli Lily and Company, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Pfizer Inc., and Sanofi S.A..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuropathic Pain Drug Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neuropathic Pain Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuropathic Pain Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuropathic Pain Drug Market?
4. What is the competitive strategic window for opportunities in the Global Neuropathic Pain Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Neuropathic Pain Drug Market?
6. What are the modes and strategic moves considered suitable for entering the Global Neuropathic Pain Drug Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neuropathic Pain Drug Market is expected to grow from USD 8,800.80 Million in 2020 to USD 13,380.73 Million by the end of 2025.
2. The Global Neuropathic Pain Drug Market is expected to grow from EUR 7,716.71 Million in 2020 to EUR 11,732.48 Million by the end of 2025.
3. The Global Neuropathic Pain Drug Market is expected to grow from GBP 6,860.17 Million in 2020 to GBP 10,430.20 Million by the end of 2025.
4. The Global Neuropathic Pain Drug Market is expected to grow from JPY 939,269.04 Million in 2020 to JPY 1,428,063.94 Million by the end of 2025.
5. The Global Neuropathic Pain Drug Market is expected to grow from AUD 12,779.94 Million in 2020 to AUD 19,430.61 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Neuropathic Pain Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Neuropathic Pain Drug Market studied across Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy, and Trigeminal Neuralgia.
Based on Treatment, the Neuropathic Pain Drug Market studied across Antidepressant Drugs Type, Medication Type, Multimodal Therapy, and NSAIDs Type. The Antidepressant Drugs Type further studied across Serotonin Noradrenaline and Tricyclic Antidepressants. The NSAIDs Type further studied across Ibuprofen and Naproxen.
Based on Indication, the Neuropathic Pain Drug Market studied across Diabetic Neuropathy and Spinal Stenosis.
Based on Diagnosis, the Neuropathic Pain Drug Market studied across Blood Tests and Imaging Physical Examination. The Imaging Physical Examination further studied across CT, Electromyography, and MRI.
Based on Distribution, the Neuropathic Pain Drug Market studied across Online Pharmacies and Retail Pharmacies & Drug Stores.
Based on End User, the Neuropathic Pain Drug Market studied across Clinics and Hospitals.
Based on Geography, the Neuropathic Pain Drug Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuropathic Pain Drug Market including Baxter Healthcare Corporation, Biogen Idec Inc., Bristol-Myers Squibb and Company, Depomed Inc., Eli Lily and Company, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Pfizer Inc., and Sanofi S.A..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuropathic Pain Drug Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neuropathic Pain Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuropathic Pain Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuropathic Pain Drug Market?
4. What is the competitive strategic window for opportunities in the Global Neuropathic Pain Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Neuropathic Pain Drug Market?
6. What are the modes and strategic moves considered suitable for entering the Global Neuropathic Pain Drug Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Treatment Outlook
3.5. Diagnosis Outlook
3.6. Indication Outlook
3.7. End User Outlook
3.8. Distribution Outlook
3.9. Geography Outlook
3.10. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY TYPE
6.1. Introduction
6.2. Phantom Limb Pain
6.3. Post Herpetic Neuralgia
6.4. Post-traumatic Neuropathy
6.5. Trigeminal Neuralgia
7. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY TREATMENT
7.1. Introduction
7.2. Antidepressant Drugs Type
7.2.1. Serotonin Noradrenaline
7.2.2. Tricyclic Antidepressants
7.3. Medication Type
7.4. Multimodal Therapy
7.5. NSAIDs Type
7.5.1. Ibuprofen
7.5.2. Naproxen
8. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY INDICATION
8.1. Introduction
8.2. Diabetic Neuropathy
8.3. Spinal Stenosis
9. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY DIAGNOSIS
9.1. Introduction
9.2. Blood Tests
9.3. Imaging Physical Examination
9.3.1. CT
9.3.2. Electromyography
9.3.3. MRI
10. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY DISTRIBUTION
10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies & Drug Stores
11. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY END USER
11.1. Introduction
11.2. Clinics
11.3. Hospitals
12. AMERICAS NEUROPATHIC PAIN DRUG MARKET
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. South Korea
13.10. Thailand
14. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET
14.1. Introduction
14.2. France
14.3. Germany
14.4. Italy
14.5. Netherlands
14.6. Qatar
14.7. Russia
14.8. Saudi Arabia
14.9. South Africa
14.10. Spain
14.11. United Arab Emirates
14.12. United Kingdom
15. COMPETITIVE LANDSCAPE
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis
15.4. Competitor SWOT Analysis
15.5. Competitive Scenario
15.5.1. Merger & Acquisition
15.5.2. Agreement, Collaboration, & Partnership
15.5.3. New Product Launch & Enhancement
15.5.4. Investment & Funding
15.5.5. Award, Recognition, & Expansion
16. COMPANY USABILITY PROFILES
16.1. Baxter Healthcare Corporation
16.2. Biogen Idec Inc.
16.3. Bristol-Myers Squibb and Company
16.4. Depomed Inc.
16.5. Eli Lily and Company
16.6. GlaxoSmithKline PLC
16.7. Johnson & Johnson Services Inc.
16.8. Pfizer Inc.
16.9. Sanofi S.A.
17. APPENDIX
17.1. Discussion Guide
17.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Treatment Outlook
3.5. Diagnosis Outlook
3.6. Indication Outlook
3.7. End User Outlook
3.8. Distribution Outlook
3.9. Geography Outlook
3.10. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY TYPE
6.1. Introduction
6.2. Phantom Limb Pain
6.3. Post Herpetic Neuralgia
6.4. Post-traumatic Neuropathy
6.5. Trigeminal Neuralgia
7. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY TREATMENT
7.1. Introduction
7.2. Antidepressant Drugs Type
7.2.1. Serotonin Noradrenaline
7.2.2. Tricyclic Antidepressants
7.3. Medication Type
7.4. Multimodal Therapy
7.5. NSAIDs Type
7.5.1. Ibuprofen
7.5.2. Naproxen
8. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY INDICATION
8.1. Introduction
8.2. Diabetic Neuropathy
8.3. Spinal Stenosis
9. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY DIAGNOSIS
9.1. Introduction
9.2. Blood Tests
9.3. Imaging Physical Examination
9.3.1. CT
9.3.2. Electromyography
9.3.3. MRI
10. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY DISTRIBUTION
10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies & Drug Stores
11. GLOBAL NEUROPATHIC PAIN DRUG MARKET, BY END USER
11.1. Introduction
11.2. Clinics
11.3. Hospitals
12. AMERICAS NEUROPATHIC PAIN DRUG MARKET
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. South Korea
13.10. Thailand
14. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET
14.1. Introduction
14.2. France
14.3. Germany
14.4. Italy
14.5. Netherlands
14.6. Qatar
14.7. Russia
14.8. Saudi Arabia
14.9. South Africa
14.10. Spain
14.11. United Arab Emirates
14.12. United Kingdom
15. COMPETITIVE LANDSCAPE
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis
15.4. Competitor SWOT Analysis
15.5. Competitive Scenario
15.5.1. Merger & Acquisition
15.5.2. Agreement, Collaboration, & Partnership
15.5.3. New Product Launch & Enhancement
15.5.4. Investment & Funding
15.5.5. Award, Recognition, & Expansion
16. COMPANY USABILITY PROFILES
16.1. Baxter Healthcare Corporation
16.2. Biogen Idec Inc.
16.3. Bristol-Myers Squibb and Company
16.4. Depomed Inc.
16.5. Eli Lily and Company
16.6. GlaxoSmithKline PLC
16.7. Johnson & Johnson Services Inc.
16.8. Pfizer Inc.
16.9. Sanofi S.A.
17. APPENDIX
17.1. Discussion Guide
17.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 164. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 166. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 168. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 170. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 172. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 174. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 175. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 176. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 177. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 178. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 179. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 180. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 181. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 182. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 183. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 184. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 185. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 186. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 187. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 188. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 189. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 190. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 191. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 192. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 193. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 194. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 195. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 196. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 197. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 198. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 199. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 200. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 201. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 202. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 203. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 204. GLOBAL NEUROPATHIC PAIN DRUG MARKET: SCORES
TABLE 205. GLOBAL NEUROPATHIC PAIN DRUG MARKET: BUSINESS STRATEGY
TABLE 206. GLOBAL NEUROPATHIC PAIN DRUG MARKET: PRODUCT SATISFACTION
TABLE 207. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RANKING
TABLE 208. GLOBAL NEUROPATHIC PAIN DRUG MARKET: MERGER & ACQUISITION
TABLE 209. GLOBAL NEUROPATHIC PAIN DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 210. GLOBAL NEUROPATHIC PAIN DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 211. GLOBAL NEUROPATHIC PAIN DRUG MARKET: INVESTMENT & FUNDING
TABLE 212. GLOBAL NEUROPATHIC PAIN DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 213. GLOBAL NEUROPATHIC PAIN DRUG MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. AMERICAS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ARGENTINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. BRAZIL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CANADA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MEXICO NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED STATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. ASIA-PACIFIC NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. AUSTRALIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. CHINA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. INDIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. INDONESIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. JAPAN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. MALAYSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. PHILIPPINES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SOUTH KOREA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. THAILAND NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. FRANCE NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. GERMANY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. ITALY NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. NETHERLANDS NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 164. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 165. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 166. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 167. QATAR NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 168. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 169. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 170. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 171. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 172. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 173. RUSSIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 174. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 175. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 176. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 177. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 178. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 179. SAUDI ARABIA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 180. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 181. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 182. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 183. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 184. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 185. SOUTH AFRICA NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 186. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 187. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 188. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 189. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 190. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 191. SPAIN NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 192. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 193. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 194. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 195. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 196. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 197. UNITED ARAB EMIRATES NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 198. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 199. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 200. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 201. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 202. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 203. UNITED KINGDOM NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 204. GLOBAL NEUROPATHIC PAIN DRUG MARKET: SCORES
TABLE 205. GLOBAL NEUROPATHIC PAIN DRUG MARKET: BUSINESS STRATEGY
TABLE 206. GLOBAL NEUROPATHIC PAIN DRUG MARKET: PRODUCT SATISFACTION
TABLE 207. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RANKING
TABLE 208. GLOBAL NEUROPATHIC PAIN DRUG MARKET: MERGER & ACQUISITION
TABLE 209. GLOBAL NEUROPATHIC PAIN DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 210. GLOBAL NEUROPATHIC PAIN DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 211. GLOBAL NEUROPATHIC PAIN DRUG MARKET: INVESTMENT & FUNDING
TABLE 212. GLOBAL NEUROPATHIC PAIN DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 213. GLOBAL NEUROPATHIC PAIN DRUG MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2020 (USD MILLION)
FIGURE 7. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 9. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 10. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 11. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 12. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 13. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 15. GLOBAL NEUROPATHIC PAIN DRUG MARKET: MARKET DYNAMICS
FIGURE 16. GLOBAL NEUROPATHIC PAIN DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 17. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 18. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2025
FIGURE 20. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 25. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2025
FIGURE 27. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 36. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2025
FIGURE 38. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2020 VS 2025 (%)
FIGURE 41. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2025
FIGURE 43. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 49. GLOBAL NEUROPATHIC PAIN
FIGURE 1. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPATHIC PAIN DRUG MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 6. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2020 (USD MILLION)
FIGURE 7. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 9. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 10. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 11. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 12. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 13. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 15. GLOBAL NEUROPATHIC PAIN DRUG MARKET: MARKET DYNAMICS
FIGURE 16. GLOBAL NEUROPATHIC PAIN DRUG MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 17. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 18. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TYPE, 2025
FIGURE 20. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY PHANTOM LIMB PAIN, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST HERPETIC NEURALGIA, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY POST-TRAUMATIC NEUROPATHY, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 25. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TREATMENT, 2025
FIGURE 27. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SEROTONIN NORADRENALINE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MEDICATION TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MULTIMODAL THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NSAIDS TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IBUPROFEN, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY NAPROXEN, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 36. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY INDICATION, 2025
FIGURE 38. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIABETIC NEUROPATHY, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY SPINAL STENOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2020 VS 2025 (%)
FIGURE 41. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DIAGNOSIS, 2025
FIGURE 43. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY BLOOD TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY IMAGING PHYSICAL EXAMINATION, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY CT, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY ELECTROMYOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY MRI, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL NEUROPATHIC PAIN DRUG MARKET SIZE, BY DISTRIBUTION, 2020 VS 2025 (%)
FIGURE 49. GLOBAL NEUROPATHIC PAIN
